Harel Insurance Investments & Financial Services’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $181K | Sell |
500
-200
| -29% | -$68.5K | ﹤0.01% | 345 |
|
|
2026
Q1 | $246K | Buy |
700
+200
| +40% | +$71.3K | ﹤0.01% | 281 |
|
|
2025
Q4 | $164K | Buy |
+500
| New | +$159K | ﹤0.01% | 288 |
|
|
2024
Q4 | – | Sell |
-1,202
| Closed | -$387K | – | 468 |
|
|
2024
Q3 | $387K | Buy |
1,202
+106
| +10% | +$34.7K | 0.01% | 179 |
|
|
2024
Q2 | $342K | Buy |
1,096
+77
| +8% | +$22.6K | 0.01% | 202 |
|
|
2024
Q1 | $290K | Sell |
1,019
-239
| -19% | -$69.9K | 0.01% | 213 |
|
|
2023
Q4 | $363K | Buy |
1,258
+36
| +3% | +$9.81K | 0.01% | 232 |
|
|
2023
Q3 | $328K | Buy |
+1,222
| New | +$305K | 0.01% | 230 |
|
|
2023
Q2 | – | Sell |
-692
| Closed | -$167K | – | 688 |
|
|
2023
Q1 | $167K | Buy |
692
+199
| +40% | +$48.8K | ﹤0.01% | 352 |
|
|
2022
Q4 | $129K | Sell |
493
-85
| -15% | -$22.8K | ﹤0.01% | 332 |
|
|
2022
Q3 | $132K | Buy |
578
+298
| +106% | +$72.2K | ﹤0.01% | 346 |
|
|
2022
Q2 | $68K | Buy |
+280
| New | +$68.6K | ﹤0.01% | 463 |
|
|
2022
Q1 | – | Sell |
-5,300
| Closed | -$1.2M | – | 699 |
|
|
2021
Q4 | $1.2M | Sell |
5,300
-3,026
| -36% | -$639K | 0.02% | 163 |
|
|
2021
Q3 | $1.77M | Buy |
8,326
+6,870
| +472% | +$1.58M | 0.05% | 101 |
|
|
2021
Q2 | $1.16M | Buy |
1,456
+283
| +24% | +$69.6K | 0.03% | 290 |
|
|
2021
Q1 | $975K | Sell |
1,173
-4,000
| -77% | -$954K | 0.02% | 363 |
|
|
2020
Q4 | $3.83M | Sell |
5,173
-3,109
| -38% | -$717K | 0.09% | 104 |
|
|
2020
Q3 | $2.1M | Buy |
8,282
+6,222
| +302% | +$1.54M | 0.07% | 76 |
|
|
2020
Q2 | $486K | Buy |
2,060
+225
| +12% | +$51.3K | 0.02% | 131 |
|
|
2020
Q1 | $372K | Buy |
1,835
+793
| +76% | +$173K | 0.02% | 118 |
|
|
2019
Q4 | $251K | Buy |
1,042
+930
| +830% | +$205K | 0.01% | 181 |
|
|
2019
Q3 | $22K | Sell |
112
-88
| -44% | -$16.9K | ﹤0.01% | 379 |
|
|
2019
Q2 | $37K | Hold |
200
| – | – | ﹤0.01% | 341 |
|
|
2019
Q1 | $38K | Sell |
200
-300
| -60% | -$57.3K | ﹤0.01% | 290 |
|
|
2018
Q4 | $97K | Buy |
500
+300
| +150% | +$58.5K | 0.01% | 236 |
|
|
2018
Q3 | $41K | Sell |
200
-800
| -80% | -$158K | ﹤0.01% | 356 |
|
|
2018
Q2 | $185K | Buy |
1,000
+130
| +15% | +$23K | 0.01% | 191 |
|
|
2018
Q1 | $148K | Sell |
870
-38
| -4% | -$6.97K | 0.01% | 242 |
|
|
2017
Q4 | $158K | Sell |
908
-641
| -41% | -$113K | 0.01% | 231 |
|
|
2017
Q3 | $289K | Sell |
1,549
-400
| -21% | -$70.9K | 0.02% | 143 |
|
|
2017
Q2 | $336K | Sell |
1,949
-101
| -5% | -$16.4K | 0.03% | 135 |
|
|
2017
Q1 | $332K | Buy |
2,050
+2,022
| +7,221% | +$336K | 0.03% | 122 |
|
|
2016
Q4 | $4K | Hold |
28
| – | – | ﹤0.01% | 340 |
|
|
2016
Q3 | $5K | Sell |
28
-2,293
| -99% | -$388K | ﹤0.01% | 420 |
|
|
2016
Q2 | $353K | Buy |
2,321
+2,293
| +8,189% | +$356K | 0.04% | 107 |
|
|
2016
Q1 | $4K | Buy |
+28
| New | +$4.16K | ﹤0.01% | 421 |
|
Other funds holding AMGN
Harel Insurance Investments & Financial Services's AMGN Position: Q2 2026 in Review
Harel Insurance Investments & Financial Services reduced its Amgen (AMGN) stake by 29% in Q2 2026, selling an estimated $68.5K and leaving 500 shares worth $181K. The position accounts for ﹤0.01% of the portfolio, ranked #345.
Harel Insurance Investments & Financial Services first reported a position in AMGN in Q1 2016 and has held it in 36 quarters since. The position peaked at $3.83M in Q4 2020. 1,659 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Harel Insurance Investments & Financial Services held 500 shares of Amgen worth $181K as of Q2 2026.
- Harel Insurance Investments & Financial Services sold 200 Amgen shares in Q2 2026, an estimated $68.5K.
- Amgen made up ﹤0.01% of Harel Insurance Investments & Financial Services's portfolio in Q2 2026, its #345 holding.
- Harel Insurance Investments & Financial Services first reported a position in Amgen in Q1 2016 and has held it in 36 quarters since.
- Harel Insurance Investments & Financial Services's Amgen position peaked at $3.83M in Q4 2020.
- 1,659 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2026, filed 29 Jul 2026.